Healthcare systems across Asia-Pacific are facing mounting pressures from rising demand, demographic change, and fiscal constraints. At the same time, expectations for better outcomes, patient-centred care, and system sustainability continue to grow. In this context, the transition toward value-based healthcare is no longer optional—it is essential.
This position paper reflects APACMed’s sustained engagement with policymakers, health technology assessment (HTA) bodies, payers, clinicians, patient groups, and global experts to support this transition. It provides:
- A region-specific assessment of how VBHC principles are currently being applied across Asia-Pacific health systems.
- An analysis of the key structural and policy barriers that continue to limit broader VBHC adoption, particularly beyond HTA and reimbursement decision-making.
- A readiness framework categorising healthcare systems based on their maturity in enabling VBHC for MedTech.
- Practical policy pathways and recommendations to operationalise VBHC across reimbursement, procurement, data infrastructure, and stakeholder collaboration.
Importantly, the paper highlights the evolving role that medical technologies can play in enabling value-based care through stronger real-world evidence generation, digital integration, outcome measurement, and partnership models that focus on delivering measurable health outcomes rather than volume.
APACMed developed this position paper as a constructive contribution to ongoing regional policy discussions. We intend to support informed dialogue and collaboration across stakeholders, and to help accelerate a more consistent and sustainable shift toward outcomes-focused healthcare systems in Asia-Pacific.
